NCT01523717已完成不适用
Procalcitonin Decrease Over 72 Hours and Outcome in Patients With Severe Sepsis or Septic Shock
Brahms AG13 个研究点 分布在 1 个国家目标入组 858 人开始时间: 2011年12月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 858
- 试验地点
- 13
- 主要终点
- 28 day all cause mortality
研究概览
简要总结
The purpose of this study is to investigate the relationship between a procalcitonin decrease over 72 hours and outcome in patients who have severe sepsis or septic shock.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients (i.e. >18 years of age) diagnosed with severe sepsis or septic shock as defined in Appendix 1, who are already in the ICU or come from the ED, other wards or directly from out of hospital
- •Blood sample collection within 12 hours after diagnosis "severe sepsis or septic shock"No prior enrollment into this study
- •Written informed consent
排除标准
- 未提供
结局指标
主要结局
28 day all cause mortality
时间窗: within 28 day safter inlclusion
participants will be followed up for 28 days
次要结局
- all-cause in-hospital mortality(mortality during hospital stay)
研究者
研究点 (13)
Loading locations...
相似试验
已完成
不适用
Procalcitonin Use in Pneumonia Patients in the Critical Care SettingPneumoniaNCT01788488Mayo Clinic134
已完成
不适用
Procalcitonin guided reduction of the duration of antibiotic therapy in Community Acquired PneumoniaCommunity Acquired Pneumonia (CAP)RespiratoryPneumoniaISRCTN04176397niversity Hospital Basel (Switzerland)250
已完成
不适用
Effect of Procalcitonin Guidance for Duration of Antibiotic Therapy on Antibiotics Use in Aspiration Pneumonia Randomized Controlled Trialaspiration pneumoniaJPRN-UMIN000004800Hamamatsu Medical Center100
已完成
不适用
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With PneumoniaPneumoniaNCT03711227Spectrum Health - Lakeland185
Unknown
3 期
PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) TrialSepsisNCT01652404Hunan Children's Hospital600